Market Cap 3.95B
Revenue (ttm) 276.98M
Net Income (ttm) -59.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -21.48%
Debt to Equity Ratio 0.00
Volume 2,668,300
Avg Vol 3,198,988
Day's Range N/A - N/A
Shares Out 159.60M
Stochastic %K 50%
Beta 2.08
Analysts Strong Sell
Price Target $25.07

Company Profile

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient'...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 206 659 0067
Fax: 206 659 0667
Address:
1165 Eastlake Avenue East, Seattle, United States
Treasury225
Treasury225 Aug. 13 at 3:09 PM
$ADPT some low volume minor ( I say minor because theres no real reason for it) consolidation, while some shorts quietly cover at a bargain (a painful bargain). Many bullish potential scenarios lurking. MM’s should be tweaking their algorithm even greater towards the long side… many bullish scenarios lurking… expanded medicare coverage (?) new indications from abstracts (?) buyouts (?) new opportunities from note $’s (?) Harlan giving away more shares at insanely low prices (contrarian indicator) expense consolidation (!)(?)
0 · Reply
Treasury225
Treasury225 Aug. 11 at 2:22 PM
$ADPT some massive trades crossing off the tape. Volu well over 1 million.
0 · Reply
woogs22
woogs22 Aug. 4 at 8:50 PM
0 · Reply
Treasury225
Treasury225 Jul. 30 at 7:25 PM
$ADPT sorry to sound aggressive just can’t find the adjustment… plus the 10cent number was barely mentioned (and the adj not mentioned at all). Seems it has been served at the upgrade party. Greaat quarter… ok talk to me later.
0 · Reply
Treasury225
Treasury225 Jul. 30 at 12:53 PM
$ADPT so WTF is it! A ten or twenty five cent loss?
0 · Reply
EarningsInsider
EarningsInsider Jul. 29 at 9:31 PM
https://www.marketbeat.com/earnings/reports/2026-7-29-adaptive-biotechnologies-co-stock/ $ADPT Adaptive Biotechnologies Earnings Transcrip
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 29 at 8:20 PM
$ADPT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 down -47.06% YoY • Reported revenue of $71.55M up 21.53% YoY • Adaptive Biotechnologies expects full year MRD revenue between $268 million and $278 million, while total company operating expenses, including cost of revenue, are forecast between $350 million and $355 million.
0 · Reply
NevD
NevD Jul. 24 at 11:18 PM
$ADPT nice to fish green on a red day 👍🏽
0 · Reply
NevD
NevD Jul. 21 at 9:21 PM
0 · Reply
NevD
NevD Jul. 21 at 9:19 PM
$ADPT I’d be thrilled at $30+. $34 would be a gift from God
0 · Reply
Latest News on ADPT
Adaptive Biotechnologies Earnings Call Transcript: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 19 days ago

Adaptive Biotechnologies Earnings Call Transcript: Q2 2026


Adaptive Biotechnologies Earnings release: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 19 days ago

Adaptive Biotechnologies Earnings release: Q2 2026


Adaptive Biotechnologies Slides: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 19 days ago

Adaptive Biotechnologies Slides: Q2 2026


Adaptive Biotechnologies Quarterly report: Q2 2026

Jul 29, 2026, 4:30 PM EDT - 19 days ago

Adaptive Biotechnologies Quarterly report: Q2 2026


Adaptive Biotechnologies management to meet with Craig-Hallum

2026-06-16T20:17:43.000Z - 2 months ago

Adaptive Biotechnologies management to meet with Craig-Hallum


Adaptive Biotechnologies Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Adaptive Biotechnologies Earnings Call Transcript: Q1 2026


Adaptive Biotechnologies Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Adaptive Biotechnologies Earnings release: Q1 2026


Adaptive Biotechnologies Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Adaptive Biotechnologies Slides: Q1 2026


Adaptive Biotechnologies Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Adaptive Biotechnologies Quarterly report: Q1 2026


Adaptive Biotechnologies Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Adaptive Biotechnologies Proxy statement: Proxy filing


Adaptive Biotechnologies Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Adaptive Biotechnologies Proxy statement: Proxy filing


Adaptive Biotechnologies Slides: Corporate presentation

Mar 24, 2026, 7:00 AM EDT - 5 months ago

Adaptive Biotechnologies Slides: Corporate presentation


Adaptive Biotechnologies Earnings Call Transcript: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Adaptive Biotechnologies Earnings Call Transcript: Q4 2025


Adaptive Biotechnologies Annual report: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Adaptive Biotechnologies Annual report: Q4 2025


Adaptive Biotechnologies Earnings release: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Adaptive Biotechnologies Earnings release: Q4 2025


Adaptive Biotechnologies Slides: Q4 2025

Feb 5, 2026, 4:30 PM EST - 6 months ago

Adaptive Biotechnologies Slides: Q4 2025


Adaptive Biotechnologies Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Adaptive Biotechnologies Earnings Call Transcript: Q3 2025


Adaptive Biotechnologies Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Adaptive Biotechnologies Quarterly report: Q3 2025


Adaptive Biotechnologies Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Adaptive Biotechnologies Earnings release: Q3 2025


Adaptive Biotechnologies Slides: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Adaptive Biotechnologies Slides: Q3 2025


Adaptive Biotechnologies Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Earnings Call Transcript: Q2 2025


Adaptive Biotechnologies Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Quarterly report: Q2 2025


Adaptive Biotechnologies Earnings release: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Earnings release: Q2 2025


Adaptive Biotechnologies Slides: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Slides: Q2 2025


Adaptive Biotechnologies Earnings Call Transcript: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Earnings Call Transcript: Q1 2025


Adaptive Biotechnologies Quarterly report: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Quarterly report: Q1 2025


Adaptive Biotechnologies Earnings release: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Earnings release: Q1 2025


Adaptive Biotechnologies Slides: Q1 2025

May 1, 2025, 4:30 PM EDT - 1 year ago

Adaptive Biotechnologies Slides: Q1 2025


Adaptive Biotechnologies Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Adaptive Biotechnologies Proxy statement: Proxy Filing


Adaptive Biotechnologies Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Adaptive Biotechnologies Proxy statement: Proxy Filing


Adaptive Biotechnologies Earnings Call Transcript: Q4 2024

Feb 11, 2025, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Earnings Call Transcript: Q4 2024


Adaptive Biotechnologies Annual report: Q4 2024

Feb 11, 2025, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Annual report: Q4 2024


Adaptive Biotechnologies Earnings release: Q4 2024

Feb 11, 2025, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Earnings release: Q4 2024


Adaptive Biotechnologies Slides: Q4 2024

Feb 11, 2025, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Slides: Q4 2024


Adaptive Biotechnologies Slides: FY 2025

Jan 14, 2025, 8:15 PM EST - 1 year ago

Adaptive Biotechnologies Slides: FY 2025


Adaptive Biotechnologies Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Earnings Call Transcript: Q3 2024


Adaptive Biotechnologies Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Quarterly report: Q3 2024


Adaptive Biotechnologies Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Earnings release: Q3 2024


Adaptive Biotechnologies Slides: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Adaptive Biotechnologies Slides: Q3 2024


Adaptive Biotechnologies Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Earnings Call Transcript: Q2 2024


Adaptive Biotechnologies Quarterly report: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Quarterly report: Q2 2024


Adaptive Biotechnologies Earnings release: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Earnings release: Q2 2024


Adaptive Biotechnologies Slides: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Slides: Q2 2024


Adaptive Biotechnologies Proxy statement: Proxy Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

Adaptive Biotechnologies Proxy statement: Proxy Filing


Adaptive Biotechnologies Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Earnings Call Transcript: Q1 2024


Adaptive Biotechnologies Quarterly report: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Quarterly report: Q1 2024


Adaptive Biotechnologies Earnings release: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Earnings release: Q1 2024


Adaptive Biotechnologies Slides: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Adaptive Biotechnologies Slides: Q1 2024


Adaptive Biotechnologies Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Adaptive Biotechnologies Proxy statement: Proxy Filing


Adaptive Biotechnologies Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Adaptive Biotechnologies Proxy statement: Proxy Filing


Treasury225
Treasury225 Aug. 13 at 3:09 PM
$ADPT some low volume minor ( I say minor because theres no real reason for it) consolidation, while some shorts quietly cover at a bargain (a painful bargain). Many bullish potential scenarios lurking. MM’s should be tweaking their algorithm even greater towards the long side… many bullish scenarios lurking… expanded medicare coverage (?) new indications from abstracts (?) buyouts (?) new opportunities from note $’s (?) Harlan giving away more shares at insanely low prices (contrarian indicator) expense consolidation (!)(?)
0 · Reply
Treasury225
Treasury225 Aug. 11 at 2:22 PM
$ADPT some massive trades crossing off the tape. Volu well over 1 million.
0 · Reply
woogs22
woogs22 Aug. 4 at 8:50 PM
0 · Reply
Treasury225
Treasury225 Jul. 30 at 7:25 PM
$ADPT sorry to sound aggressive just can’t find the adjustment… plus the 10cent number was barely mentioned (and the adj not mentioned at all). Seems it has been served at the upgrade party. Greaat quarter… ok talk to me later.
0 · Reply
Treasury225
Treasury225 Jul. 30 at 12:53 PM
$ADPT so WTF is it! A ten or twenty five cent loss?
0 · Reply
EarningsInsider
EarningsInsider Jul. 29 at 9:31 PM
https://www.marketbeat.com/earnings/reports/2026-7-29-adaptive-biotechnologies-co-stock/ $ADPT Adaptive Biotechnologies Earnings Transcrip
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Jul. 29 at 8:20 PM
$ADPT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 down -47.06% YoY • Reported revenue of $71.55M up 21.53% YoY • Adaptive Biotechnologies expects full year MRD revenue between $268 million and $278 million, while total company operating expenses, including cost of revenue, are forecast between $350 million and $355 million.
0 · Reply
NevD
NevD Jul. 24 at 11:18 PM
$ADPT nice to fish green on a red day 👍🏽
0 · Reply
NevD
NevD Jul. 21 at 9:21 PM
0 · Reply
NevD
NevD Jul. 21 at 9:19 PM
$ADPT I’d be thrilled at $30+. $34 would be a gift from God
0 · Reply
Treasury225
Treasury225 Jul. 21 at 2:45 PM
$ADPT WOW! What’s with all the volume today??? Even a guess is appreciated
1 · Reply
machusa
machusa Jul. 15 at 11:53 PM
$ASTS in AH @ $58.03 Sold $ADPT to do it. +30% IDK... $70 was cheap for ASTS so I had to give it a shot.
0 · Reply
TalkMarkets
TalkMarkets Jul. 14 at 4:21 PM
SMID Biotech Stocks Were Cruising To New Highs Until Friday’s Speed Bump $ABBV $ADPT $AMRX $ARKG $BAX https://talkmarkets.com/article/smid-biotech-stocks-were-cruising-to-new-highs-until-fridays-speed-bump-1784045167
0 · Reply
NevD
NevD Jul. 10 at 10:24 PM
$ADPT bought 5 shares. Giddy Up
0 · Reply
Treasury225
Treasury225 Jul. 10 at 7:58 PM
$ADPT this stock is a safe haven… looking forward to earnings
0 · Reply
iBio_GlaisterPIT
iBio_GlaisterPIT Jul. 9 at 2:30 PM
$ADPT here’s the nice part for us. While the conversion price of the recent convertible senior notes issuance was set at $24.11, they bought capped calls up to $34.44. In a nutshell, convertible senior notes get converted to stock if they hit the conversion price. Meaning, you could have an influx of shares, or dilution. But because they also purchased insurance, by way of the capped calls, there shouldn’t be much dilution at all, unless the sp pushes beyond $34.44. Hopefully that adds a little color.
1 · Reply
mbl36
mbl36 Jul. 8 at 8:48 PM
$UNH $ARE $ADPT Lets go 🚀
1 · Reply
Treasury225
Treasury225 Jul. 8 at 2:13 PM
$ADPT whenever i dis Guggenheim i get put in my place. I’m thinking they will upgrade once earnings come out. IMO earnings will be good because i don’t think they could have pulled off that savvy note deal without showing strength.
0 · Reply
EquityResearch6
EquityResearch6 Jul. 2 at 7:53 PM
This might be the fastest way to accumulate $1 million by the end of 2026: $DNA (Ginkgo Bioworks) → $8 Must buy $IONQ (IonQ) → $46 Must buy $EDIT (Editas Medicine) → $3.56 Must buy $FATE (Fate Therapeutics) → $3 Must buy $ADPT (Adaptive Biotechnologies) → $18 Must buy Next alert dropping soon! If you are not following us with notifications turned on, you might miss our next alerts. NFA
2 · Reply
Treasury225
Treasury225 Jun. 30 at 1:17 PM
$ADPT guggenheim raised their price target to 22…. How lame is that. This is gonna put support in at 24 b4 ya know it.
2 · Reply
ChurxyChurx
ChurxyChurx Jun. 29 at 7:46 AM
$ADPT Big BULL Big %
0 · Reply
JFDI
JFDI Jun. 28 at 11:21 PM
$ADPT B/O
0 · Reply